Publications by authors named "Lindsey Mayer"
Article Synopsis
- Circulating tumor DNA (ctDNA) is not very effective for detecting molecular residual disease (MRD) in bladder cancer, so researchers turned to analyzing urine samples instead.
- They used advanced sequencing techniques on urine tumor DNA from 74 patients, finding that urine-derived DNA markers were much better at predicting MRD than blood ctDNA.
- Their model showed 87% sensitivity for predicting residual disease and highlighted that patients identified with MRD had significantly worse outcomes in both progression-free and overall survival.
The goal of the study was to develop and test an automated short message service (SMS) and web service platform using CareSignal for remote symptom monitoring in a diverse population of patients with cancer. Twenty-eight patients with cancer undergoing radiotherapy were recruited at the start of their treatment regimen. Patients received a weekly SMS symptom survey to assess the severity of the side effects they experienced from treatment.
View Article and Find Full Text PDF